Quinapril vs lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Antihypertensive Efficacy: Quinapril vs Lisinopril
Several studies have compared the blood pressure-lowering effects of quinapril and lisinopril in patients with mild to moderate hypertension. Both drugs are effective, but some differences have been observed. Lisinopril generally shows a more significant reduction in blood pressure and a higher rate of blood pressure normalization compared to quinapril, especially when measured over 24 hours using ambulatory blood pressure monitoring (ABPM) 134. In one study, lisinopril normalized blood pressure in 83% of patients, while quinapril did so in 45% . However, another study found that quinapril led to a greater fall in blood pressure and heart rate at certain time points early in treatment . Both drugs significantly reduce systolic and diastolic blood pressure, but lisinopril tends to provide more consistent control throughout the day 134.
Blood Pressure Control in Special Populations
In elderly patients with low blood renin, both quinapril and lisinopril were effective and well-tolerated. However, quinapril provided a more constant control of hypertension in this group . This suggests that patient characteristics may influence which drug is more effective.
Heart Rate and Metabolic Effects
Quinapril has been shown to reduce heart rate significantly in some studies, while lisinopril does not have a notable effect on heart rate . Both drugs can increase serum potassium levels, but there are no significant differences between them in this regard . In terms of metabolic effects, lisinopril may have a slightly greater positive impact on insulin sensitivity compared to quinapril, which could be relevant for patients with insulin resistance or diabetes .
Tissue and Enzyme Inhibition Differences
Quinapril and lisinopril differ in their ability to inhibit angiotensin-converting enzyme (ACE) in various tissues. Quinaprilat, the active form of quinapril, is more potent than lisinopril in inhibiting ACE in plasma, lung, kidney, and heart tissues . However, lisinopril shows better inhibition of certain enzymes (carbonic anhydrases CA I and II) in laboratory studies, which may have implications for other physiological effects .
Safety and Tolerability
Both drugs are generally safe and well-tolerated. However, in laboratory studies with rat liver cells, quinapril showed higher cytotoxicity compared to lisinopril, which did not show evidence of liver cell toxicity even at high concentrations . This suggests that lisinopril may have a more favorable safety profile regarding liver toxicity.
Conclusion
Both quinapril and lisinopril are effective ACE inhibitors for treating mild to moderate hypertension. Lisinopril tends to provide more consistent blood pressure control and may have a better safety profile, especially regarding liver toxicity. Quinapril may offer more constant blood pressure control in certain populations, such as elderly patients with low renin, and can reduce heart rate. The choice between these drugs may depend on individual patient characteristics and specific clinical needs 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic